Vitality Watch

Dossier rss preclinical 23-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape

Key claim: Transplanting elderly human gut microbiota into pigs reprograms intestinal barrier function, the plasma metabolome, and the gut mucosal transcriptomic landscape.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

Most FMT-for-aging enthusiasm rests on associations and small human pilots; a large-animal transplant showing that elderly human microbiota alone can reshape barrier, metabolome, and mucosal gene expression tightens the causal chain from aged microbiome to host aging phenotypes. It matters to the trend surface because clinics and podcasts already invoke this causal story to justify young-donor FMT — the pig data supports the mechanism direction (aged → aged-like host) without validating the therapeutic direction (young → rejuvenation).

Source

Link

Briefing card

Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape
Stage: preclinical · rss · 23-sep-2026

Applies to researchers and companies building fecal-microbiota or postbiotic therapies for aging: aged human microbiota now shows host-reprogramming effects in a large-animal model, not just mice.

Transplanting elderly human gut microbiota into pigs reprograms intestinal barrier function, the plasma metabolome, and the gut mucosal transcriptomic landscape.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70725?af=R

build build 880 · 2bcef25 · 2026-11-18